361 Capital’s Madison Square Garden MSGS Stock Holding History

361 Capital’s Portfolio MSGS Stock Details MSGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,126	Closed	-$863K	–	363
2019 Q1	$863K	Buy	+4,126	New	+$838K	0.15%	221

Other funds holding MSGS

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

MWA

Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

361 Capital's MSGS Position: Q2 2019 in Review

361 Capital sold out of Madison Square Garden (MSGS) in Q2 2019, closing a stake of 4,126 shares — an estimated $863K sold.

361 Capital first reported a position in MSGS in Q1 2019 and held it in 1 quarter. The position peaked at $863K in Q1 2019. 332 funds tracked by Wall St. Rank hold MSGS as of Q2 2019.

361 Capital reported no remaining Madison Square Garden position as of Q2 2019 after selling out during the quarter.
361 Capital sold 4,126 Madison Square Garden shares in Q2 2019, an estimated $863K.
361 Capital first reported a position in Madison Square Garden in Q1 2019 and held it in 1 quarter.
361 Capital's Madison Square Garden position peaked at $863K in Q1 2019.
332 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2019.

Based on 361 Capital's 13F filing for Q2 2019, filed 7 Aug 2019.